Chromatin/Epigenetics
Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
- A4497 PyroxamideTarget: Histone Deacetylases (HDACs)Summary: HDAC1 inhibitor
- A4499 TC-H 106Summary: HDAC inhibitor
- A4501 Tubacin3 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
- A4502 ChaetocinSummary: SUV39H1 Inhibitor
- A4504 UNC 0646Summary: G9a and GLP inhibitor
- A4505 ChetominSummary: A4505 inhibitor
- A4507 KC7F2Summary: HIF-1α inhibitor
- A4508 ML 228Summary: HIF pathway activator
- A4509 PX 12Target: TrxSummary: Trx-1 inhibitor
- A4510 1,2,3,4,5,6-HexabromocyclohexaneSummary: JAK2 tyrosine kinase inhibitor